EU Policies

Health becomes a trade secret

The European Parliament has approved a new Directive on Trade Secrets which, according to the European Public Health Alliance (EPHA) means that trade secrets will outweigh the public interest. EPHA believes there will be a negative impact on health as information on the safety of medicines will be considered commercially confidential and kept secret from […]

Health becomes a trade secret Read More »

Obesity in the EU

In Europe today, 6 of the 7 biggest risk factors for premature death – blood pressure, cholesterol, Body Mass Index, inadequate fruit and vegetable intake, physical inactivity and alcohol abuse – relate to how we eat, drink and move. Rising overweight and obesity across Europe is particularly worrying. The European Commission advocates an integrated approach,

Obesity in the EU Read More »

Healthy and sustainable food production

There are considerable obstacles to integrating public health concerns into European agricultural policy. Advocates for healthy food and drink environments are routinely confronted with an oversimplified narrative about growth and jobs. But times are changing; in the recent debates around developing a more sustainable and broader food policy, the discussion is moving beyond the agriculture

Healthy and sustainable food production Read More »

European Reference Networks

Imagine if the best specialists from across Europe could join their efforts to tackle complex or rare medical conditions that require highly specialised healthcare and a concentration of knowledge and resources. That’s the purpose of the European Reference Networks. Interest in becoming part of a Network can be registered from the 16 March 2016 and an

European Reference Networks Read More »

Orphan medicinal products

The European Commission has published an inventory of Union and Member State incentives to support research into, and the development and availability of, orphan medicinal products. To date, the Commission has authorised 117 orphan medicines for the benefit of patients suffering from rare diseases, 82{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of which are new active substances. Around 25 of the

Orphan medicinal products Read More »

Priority medicines

The European Medicines Agency has launched the PRIME (PRIority MEdicines) scheme, which offers early, proactive and enhanced support to medicine developers to optimise the production of robust data on a medicine’s benefits and risks and enable accelerated assessment. To support earlier access to patients, the Commission has shortened the timeframe for adopting decisions that authorise

Priority medicines Read More »

EU Health Programme 2014-2020

The Health Programme has a total budget of close to €450 million for 2014-2020 and it supports Member States’ efforts in four specific areas: Promoting health, preventing diseases, and fostering healthy lifestyles. Protecting citizens from serious cross-border health threats. Supporting capacity building and contributing to innovative, efficient and sustainable health systems. Facilitating access to better

EU Health Programme 2014-2020 Read More »

European medical corps

The European Union has set up a European Medical Corps (EMC) through which teams and equipment from the EU Member States can be rapidly deployed. At the moment, nine member states have offered teams and equipment to the corps. For more information about the European Medical Corps, on the europa.eu website

European medical corps Read More »

Scroll to Top